117 related articles for article (PubMed ID: 7721164)
1. [Use of aminoglutethimide in the hormonal treatment of patients with advanced breast cancer].
Wojtacki J; Dziewulska-Bokiniec A; Czech I
Ginekol Pol; 1994 Sep; 65(9):508-11. PubMed ID: 7721164
[TBL] [Abstract][Full Text] [Related]
2. [Early results of hormonal treatment of advanced breast cancer with aminoglutethimide].
Pieńkowski T; Zborzil J; Siedlecki P; Flis E; Pałucka A; Pieńkowska F; Rubách M; Piotrowski J
Pol Tyg Lek; 1988 Aug; 43(33):1057-9. PubMed ID: 3072540
[No Abstract] [Full Text] [Related]
3. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
Harris AL; Powles TJ; Smith IE
Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
[TBL] [Abstract][Full Text] [Related]
4. Aminoglutethimide in the management of metastatic breast cancer.
Savaraj N; Troner MB
Med Pediatr Oncol; 1980; 8(3):251-63. PubMed ID: 7464686
[TBL] [Abstract][Full Text] [Related]
5. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
Höffken K; Kempf H; Miller AA; Miller B; Schmidt CG; Faber P; Kley HK
Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
[TBL] [Abstract][Full Text] [Related]
6. Aminoglutethimide as second line therapy in advanced breast cancer.
Elomaa I; Blomqvist C; Rissanen P
Breast Cancer Res Treat; 1986; 7 Suppl():S51-4. PubMed ID: 3017481
[TBL] [Abstract][Full Text] [Related]
7. [Low-dose aminoglutethimide (500 mg/day) and hydrocortisone (30 mg/day) in advanced cancer of breast].
Bonneterre J; Pion JM; Demaille A
Bull Cancer; 1987; 74(3):241-7. PubMed ID: 3304478
[TBL] [Abstract][Full Text] [Related]
8. Aminoglutethimide in the treatment of metastatic breast cancer.
Troner MB
Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
[TBL] [Abstract][Full Text] [Related]
9. Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Harris AL; Cantwell BM; Sainsbury JR; Needham G; Evans RG; Dawes PJ; Wilson R; Farndon J
Breast Cancer Res Treat; 1986; 7 Suppl():S41-4. PubMed ID: 3742063
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors affecting response to aminoglutethimide in advanced breast cancer.
Brufman G
Anticancer Res; 1993; 13(4):1235-7. PubMed ID: 8352549
[TBL] [Abstract][Full Text] [Related]
11. Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Cocconi G; Bisagni G; Ceci G; Bacchi M; Boni C; Brugia M; Carpi A; Di Costanzo F; Franciosi V; Gori S
J Clin Oncol; 1992 Jun; 10(6):984-9. PubMed ID: 1588379
[TBL] [Abstract][Full Text] [Related]
12. Aminoglutethimide for the treatment of advanced postmenopausal breast cancer.
Harris AL; Powles TJ; Smith IE; Coombes RC; Ford HT; Gazet JC; Harmer CL; Morgan M; White H; Parsons CA; McKinna JA
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):11-17. PubMed ID: 6682769
[TBL] [Abstract][Full Text] [Related]
13. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer.
Harris AL; Cantwell BM; Carmichael J; Dawes P; Robinson A; Farndon J; Wilson R
Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1105-11. PubMed ID: 2759165
[TBL] [Abstract][Full Text] [Related]
15. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
Rose C; Kamby C; Mouridsen HT; Bastholt L; Brincker H; Skovgaard-Poulsen H; Andersen AP; Loft H; Dombernowsky P; Andersen KW
Breast Cancer Res Treat; 1986; 7 Suppl():S45-50. PubMed ID: 3527306
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
17. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer].
Schmidt UM; Brockmann B; Geschke E
Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564
[TBL] [Abstract][Full Text] [Related]
18. [Aminoglutethimide therapy in advanced breast cancer].
Kühböck J; Ludwig H; Pötzi P; Zielinski C
Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
[TBL] [Abstract][Full Text] [Related]
19. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
Brufman G; Biran S
Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
[TBL] [Abstract][Full Text] [Related]
20. Trial of aminoglutethimide vs hydrocortisone as second-line hormone treatment of advanced breast cancer.
Mercer PM; Ebbs SR; Fraser SC; Coltart RS; Bates T
Eur J Surg Oncol; 1993 Jun; 19(3):254-8. PubMed ID: 8314383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
